The nation of Zimbabwe has turned down a significant American health deal valued at $367m (272 million pounds) over five years because of Washington's demand for sensitive information.
This rejection came to light following a government memo from December was leaked, revealing that President Emmerson Mnangagwa believed the agreement was "skewed".
A government spokesman later explained that the United States was demanding access to health data for scientific study and commercial purposes while was unwilling to guarantee the resulting advantages from future treatments.
"We will now turn to the difficult and regrettable task of ending our health assistance in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy said the United States had furnished more than $1.9bn for health programmes to Zimbabwe during the past twenty years.
A medical body in Zimbabwe has urged continued dialogue to reach a deal suitable to all parties so the country's vital HIV treatment initiative can be sustained.
Wider Implications
This rejection follows a comparable case in Kenya, where a high court halted a similar health funding agreement following concerns were raised about the security of citizens' health data.
After resuming the presidency recently, US President Donald Trump has reduced overseas assistance and shut down the key foreign aid agency.
The agency had administered assistance for the US government, but Trump claimed its expenditure was "inefficient" and his government was pursuing direct bilateral deals to enhance openness and accountability.
As per reports, 16 nations in Africa have to date agreed to these new agreements, representing more than $18.3bn in new funding.
Specifics of the Declined Agreement
The funds for Zimbabwe was intended to funded "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"We are confident this cooperation could have provided extraordinary benefits for the people of Zimbabwe, especially the 1.2 million currently receiving antiretroviral therapy via US-supported initiatives," Tremont said.
However, government spokesperson Nick Mangwana said the proposed deal was "unfair".
"The proposal required Zimbabwe to provide its genetic material and health information for a long time, without any corresponding promise of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that might result from that shared data," Mangwana explained.
"Effectively, our nation would supply the basic resources for medical research without any assurance that the end products would be accessible to our citizens if a future pandemic emerge."
Sovereignty and Global Health
Mangwana further pointed out that the US's withdrawal from the global health body and its pursuit of bilateral deals were undermining structures already established through the global organization.
Mangwana cited its Pathogen Access and Benefit Sharing scheme designed to manage future pandemics.
"This framework is intended to guarantee that when a country contributes its information, the benefits – including vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the funds to create them."
These objections over the US deal "must not be interpreted as anti-American sentiment," Mangwana stressed.
"We are open to ongoing dialogue with our American counterparts on how future co-operation might be structured in a manner that respects the independence and dignity of each country."
Health Experts Response
Medical experts said it acknowledged the official position, but urged that negotiations should continue considering a large portion of the country's HIV programmes were funded by external financing.
"If specific concerns exist, including those involving information security or agreement terms, these can often be resolved via detailed discussion and negotiated safeguards," the group added.
The halted deal highlights the continuing challenges between accepting much-needed international aid and safeguarding a country's data in an increasingly interconnected world.